1. Home
  2. XLO vs GROV Comparison

XLO vs GROV Comparison

Compare XLO & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$9.01

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.23

Market Cap

52.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
GROV
Founded
2016
2016
Country
United States
United States
Employees
N/A
295
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
52.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
XLO
GROV
Price
$9.01
$1.23
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$28.00
$1.60
AVG Volume (30 Days)
27.3K
57.3K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,766,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$168.77
$6.81
P/E Ratio
N/A
N/A
Revenue Growth
589.88
N/A
52 Week Low
$0.46
$1.05
52 Week High
$9.30
$1.60

Technical Indicators

Market Signals
Indicator
XLO
GROV
Relative Strength Index (RSI) 65.15 53.65
Support Level $7.47 $1.19
Resistance Level $8.97 $1.47
Average True Range (ATR) 0.50 0.07
MACD 0.09 0.00
Stochastic Oscillator 81.49 95.00

Price Performance

Historical Comparison
XLO
GROV

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with a human and environmental focus. The Company sells its products through a direct-to-consumer (DTC) platform and the Company's mobile applications, where the Company sells products from Grove-owned brands (Grove Brands) and third-parties.

Share on Social Networks: